ASAM Release COVID-19 Addiction Treatment Clinical Guidance & Resources

March 20, 2020

As the leader in developing clinical guidelines and standards in addiction medicine, we take our responsibility very seriously.  We realize that many providers and programs are trying to mitigate circumstances related to COVID-19. We have convened the ASAM Caring for Patients During the COVID-19 (CPDC) Task Force. The Task Force includes a national panel of experts that are recognized in the field of addiction medicine. They are rapidly producing comprehensive resources tailored to addiction medicine treatment within the context of the COVID-19 pandemic.

To address the urgency of the situation, we will provide these resources in real-time as we have them developed. Physicians should use their personal and professional judgment in interpreting these guidances and applying them to the particular circumstances of their individual patients and practice arrangements.

These materials are provided for educational and informational purposes only. This guidance is not intended to provide legal or medical advice and should not be relied upon as such.